Newsletter | November 16, 2026

11.16.26 -- Overlooked Aspects Of Cell Line Development

SPONSOR

Less complexity. More possibility.

What could change when complex ex vivo workflows are replaced by a simpler path to delivering therapies in the body?

FOCUS ON UPSTREAM MANUFACTURING

Overlooked Aspects Of Cell Line Development

This opening segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” features panelists Ted Peters, Ph.D., head of cell line development at Immunome, and Ronan O’Kennedy, Ph.D., from ROK Bioconsulting. Peters and O’Kennedy begin by talking about the areas of cell line development they feel are often overlooked, including the alignment of early-stage work with later-stage work.

From Gene Editing To NGS-Based T Cell Characterization

Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

Perfusion Cultivations With NIST CHO Cells

Execute stable long-term perfusion with automated volume, feed, and biomass control. Maintain cell viability and high volumetric productivity with integrated bioreactor systems.

Best Practices To Increase Reliability And Resilience

Strengthen your biomanufacturing reliability with five essential habits focused on preventive care, skilled operators, smart spare‑parts planning, proactive maintenance, and expert support.

From Black Box To Precision: A New Era Of Glycan Control

Shift from unpredictable cell-line engineering to an enzymatic post-production step. Learn how this paradigm shift eliminates biological variability to ensure optimal drug performance.

Expanding The Capabilities Of Targeted Integration

See the demonstration of precise, site‑specific integration of a 50 kb multi‑gene construct into human iPSCs, overcoming size limits of traditional genome‑engineering approaches.

Unlocking The Potential Of Gamma Delta T Cell-Based Therapies

Learn more about two unique methods for clinical-scale expansion of gamma delta T cells, which are well suited for a wide variety of treatments due to their reduced risk of graft-versus-host disease.

Accelerating Multispecific Biologics: Overcoming Light Chain Mispairing

Bispecific discovery depends on solving light chain mispairing without a common light chain. Retaining native IgG attributes may shorten the path from lead optimization to stable CHO cell lines.

Beyond The Bioreactor Scaling CGT Ancillary Materials

Growing demand for cell and gene therapies is increasing pressure on cytokine production. Examine interleukin manufacturing, quality, consistency, safety, scalability, and supply reliability.

Achieve Higher Productivity With A Next-Generation Transfection Reagent

Read about a next-generation transfection system that requires 50% less plasmid, decreases transfection reagent consumption, and yields higher AAV productivity to reduce cost per dose.

Materials, Media Composition, And Decisions That Shape Cell Therapies

Discover how variability in patient-derived starting materials, serum dependence, cytokine selection, and platform lock-in create downstream risks that proactive process design can help prevent.

Extracellular Secretion Of Recombinant Proteins: Proof-Of-Principle Data

Delve into experimental approaches to extracellular protein secretion that streamline recovery and improve product quality. See proof-of-principle data across multiple protein types and molecular weights.

Providing Solutions In Titer, Host Cell Protein, And Scalability

By leveraging expertise across a global network and executing a streamlined, rapid technology transfer, take a look at how we were able to enable a highly data-driven approach to clone selection.

UPSTREAM MANUFACTURING SOLUTIONS

•

Closed System Cell Culture Flasks - Corning Life Sciences

•

A Bench-Top Bioreactor - INFORS HT

•

Enabling Advanced Bioprocessing: Solutions That Challenge The Status Quo - Repligen

•

Quantum Flex Cell Expansion System - Terumo BCT

•

Closed Process Solutions For Cell Therapy - ACROBiosystems

•

Powerful And Comprehensive Cell Culture Profiling - Roche CustomBiotech

SPONSOR

Webinar: Process Intensification Beyond mAbs: Advancing Perfusion Manufacturing for Cell & Gene Therapies

How can upstream process intensification improve cell and gene therapy manufacturing? Join Repligen to explore how perfusion and advanced cell retention technologies can boost cell density, increase productivity, and address scale-up challenges across lentiviral vector, CAR-T, NK cell, and iPSC manufacturing. Discover practical strategies for improving efficiency while maintaining critical quality attributes and reducing manufacturing costs. Click here to learn more.

SPONSOR

Webinar: Increase mAb Purification Productivity with HIC: A Step-by-Step Development Case Study

How close are we to autonomous GMP manufacturing? Join our expert panel on November 17, 2026, at 11 AM ET to explore the future of predictive control. Discover how top companies bridge the gap between automation and process modeling using PAT, soft sensors, and digital twins. Learn what it takes to validate these models and transition safely from lab to commercial scale. Register now to secure your spot!

Connect With Bioprocess Online: